CRP and Cachexia: The mGPS is an inflammatory score that correlates with sarcopenia7 and tumor cachexia.16 The term laboratory cachexia has been defined similarly to mGPS as a CRP level greater than 10 mg/L and coinciding albumin less than 35 g/L by Gray et al.17 Of note, the prevalence of laboratory cachexia increases markedly up to 85% 0 to 30 days before death.17 These data underscore the high mortality in patients with a high-risk mGPS constellation and laboratory cachexia and suggest that the mGPS is capable of measuring not only tumor dynamics but also the patient’s inflammatory and metabolic status.